Online inquiry

IVTScrip™ mRNA-Human AMOTL2, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK19657MR)

This product GTTS-WK19657MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 1 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the AMOTL2 protein. This product can be used in Oligodendrocyte-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_001278683.1
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 51421
UniProt ID Q9Y2J4
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human AMOTL2, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK19657MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK11609MR IVTScrip™ mRNA-Human ADAMTSL3, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ADAMTSL3
GTTS-WK18000MR IVTScrip™ mRNA-Human APBB2, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA APBB2
GTTS-WK28637MR IVTScrip™ mRNA-Human ARL16, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ARL16
GTTS-WK22949MR IVTScrip™ mRNA-Human ARL6IP5, (Cap 0, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ARL6IP5
GTTS-WK10799MR IVTScrip™ mRNA-Human AGGF1, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA AGGF1
GTTS-WK8600MR IVTScrip™ mRNA-Human ADAMTS16, (Cap 0, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ADAMTS16
GTTS-WK10073MR IVTScrip™ mRNA-Human ACTR3B, (Cap 0, 2-Thio-UTP, 30 nt-poly(A)) mRNA ACTR3B
GTTS-WK12673MR IVTScrip™ mRNA-Human ABI1, (Cap 1, Pseudo-UTP, 30 nt-poly(A)) mRNA ABI1
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →